"class","drug","links","Example(s) of drugs:","Mechanism of action:","Indication(s):","Side effects:","Important pharmacokinetics / pharmacodynamics:","Patient information:","Other information:"
"Haematological"," Anti-Platelet Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29277","Acetylsalicylic acid (Aspirin)","Irreversible inactivation of cyclooxygenase (COX) enzyme., This reduces platelet thromboxane (TXA2) production and endothelial prostaglandin (PGI2) production., Reduced platelet thromboxane production reduces platelet aggregation and thrombus formation, Reduced prostaglandin synthesis decreases nociceptive sensitisation and inflammation.","Secondary prevention of thrombotic events, Pain relief","Bleeding (<1% Patients), Peptic ulceration, Angiooedema, Bronchospasm, Reye’s syndrome (very rare)","Half life becomes longer with very large doses (pharmacokinetics may be non-linear in overdose)","Avoid over the counter preparations that contain aspirin., Some patients may be advised to take a Proton Pump Inhibitor alongside long-term aspirin. ","NA"
"Haematological"," Anti-Platelet Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29278","Clopidogrel","Irreversibly blocks the ADP-receptor on platelet cell membranes., Consequently inhibits formation of GPIIb/IIIa complex, required for platelet aggregation., Decreased thrombus formation.","Secondary prevention of thrombotic events","Bleeding (1-10% of Patients), Abdominal pain / diarrhoea (1-10% of Patients)","Avoid in liver failure","Patients may be advised to stop clopidogrel before surgical procedures., Patients should not stop clopidogrel without consulting their doctor if they have an arterial stent in-situ.","NA"
"Haematological"," Recombinant Tissue Plasminogen Activator (rtPA) ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29279","Tenecteplase, Alteplase","Recombinant form of tissue plasminogen activator, Catalyses conversion of plasminogen to plasmin, Promotes fibrin clot lysis","Acute ischaemic stroke within 4.5 hours of onset, Myocardial infarction within 12 hours of onset, Massive pulmonary embolism","Bleeding, Allergic reaction / angiooedema (1%)","Bolus-infusion regimen is used for alteplase , Tenecteplase is given as a single bolus, Pharmacodynamic interactions with other blood thinners (antiplatelets / anticoagulants)","When using thrombolytic drugs, patients should be made aware of the risk-benefit ratio, which should include reference to the rate of bleeding complications.","NA"
"Haematological"," Heparins ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29280","Unfractionated Heparin","Enhances activity of antithrombin III., Antithrombin III inhibits thrombin., Heparins also inhibit multiple other factors of the coagulation cascade., This produces its anticoagulant effect.","Treatment and prophylaxis of thromboembolic diseases, including induction of vitamin K antagonists., Renal dialysis (haemodialysis), Acute Coronary Syndrome treatment","Bleeding (Major haemorrhage risk can be as high as 3.5%), Heparin-induced thrombocytopenia, Osteoporosis","Administered by continuous intravenous infusion or subcutaneous injection, Complex kinetics  - non-linear relationship between dose / half-life and effect – needs TDM, Effect monitored using activated partial thromboplastin time (aPTT), Anticoagulant effect can be reversed with protamine., Unfractionated heparin has a shorter duration of action than LMW Heparin., Used in preference to LMW Heparin, in selected patients, due to the shorter duration of action and reversability with protamine (for example, Peri-operatively.)","Risk of bleeding, Regular blood monitoring required","NA"
"Haematological"," Heparins ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29281","Low Molecular Weight Heparin","Enhances activity of antithrombin III., Antithrombin III inhibits thrombin., Heparins also inhibit multiple other factors of the coagulation cascade., This produces its anticoagulant effect.","Treatment and prophylaxis of thromboembolic diseases, including induction of vitamin K antagonists., Renal dialysis (haemodialysis), Acute Coronary Syndrome treatment","Bleeding (Major haemorrhage risk can be as high as 3.5%), Heparin-induced thrombocytopenia (Less risk than unfractionated heparin), Osteoporosis (Less risk than unfractionated heparin)","Subcutaneous injection, More predictable dose-response relationship than Unfractionated Heparin., 2-4 times longer plasma half-life than Unfractionated Heparin, Clearance is mostly via a renal pathway, thus the half-life can be prolonged in patients with renal failure, so dose adjustment may be needed., Regular coagulation monitoring is not required., Less readily reversed with protamine, than Unfractionated Heparin.","Risk of bleeding, Requires injection, Will need blood testing in prolonged therapy (Full Blood Count, to monitor for thrombocytopenia).","NA"
"Haematological"," Vitamin K Antagonists ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29282","Warfarin","Inhibits vitamin K epoxide reductase., Prevents recycling of vitamin K to reduced form after carboxylation of coagulation factors II, VII, IX and X., Prevents thrombus formation.","Treatment of venous thromboembolism, Thromboprophylaxis in: AF / metallic heart valves / cardiomyopathy","Bleeding (risk increases with increasing INR), Warfarin necrosis, Osteoporosis","Numerous drug interactions / food interactions, Reversal by giving vitamin K, Polymorphisms in key metabolising enzymes (VKORC1 and CYP2C9), Needs therapeutic drug monitoring and monitored loading regimen, Monitored with INR and dose adjusted according to indication","Need for compliance / attendance at visits for monitoring, Care needed with alcohol, Must inform doctor before starting new drugs – avoid over the counter aspirin preparations","NA"
"Haematological"," Direct Thrombin Inhibitors ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29283","Dabigatran","Direct thrombin inhibitor; prevents conversion of fibrinogen to fibrin., This prevents thrombus formation.","Prophylaxis of venous thromboembolism (especially post-operative), Thromboprophylaxis in non-valvular AF","Bleeding, Dyspepsia","Rapid onset of action, No food / few drug interactions (not metabolised via CYP 450), No need for therapeutic monitoring, Currently no available antidote","Risk of bleeding","NA"
"Haematological"," Factor Xa Antagonists ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29284","Rivaroxaban","Inhibits conversion of prothrombin to thrombin, reducing concentrations of thrombin in the blood., This inhibits the formation of fibrin clots.","Prophylaxis of venous thromboembolism (especially post-operative), Thromboprophylaxis in non-valvular AF, Treatment of venous thromboembolism","Bleeding, Nausea","Predictable drug interactions (metabolised via CYP 450, inc CYP3A4), No need for therapeutic monitoring, Currently no available antidote","Risk of bleeding","NA"
"Haematological"," Factor Xa Antagonists ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29285","Apixaban","Inhibits conversion of prothrombin to thrombin; reducing concentrations of thrombin in the blood., This inhibits the formation of fibrin clots.","Prophylaxis of venous thromboembolism following hip or knee replacement surgery., Thromboprophylaxis in non-valvular AF.","Bleeding, Nausea","Predictable drug interactions (metabolised via CYP 450 and substrate for p glycoprotein), 75% is metabolised by the liver, the rest being renally excreted., No need for therapeutic monitoring, Currently no available antidote.","Risk of bleeding","NA"
"Cardiovascular"," Cardioselective Beta-Blockers ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29286","Bisoprolol, Atenolol","Cardioselective beta-1-adrenoceptor antagonist., Preferentially blocks beta-1 receptors in cardiac and renal tissue., Inhibits sympathetic stimulation of the heart and renal vasculature., Blockade of the sino-atrial node reduces heart rate (negative chronotropic effect) and blockade of receptors in the myocardium depresses cardiac contractility (negative inotropic effect)., Additionally, blockade of beta-1 adrenoceptors in renal tissue inhibits the release of renin, depressing the vasoconstrictive effects of the renin-angiotensin-aldosterone system.","Hypertension, Angina, Rate-control in atrial fibrillation, Carvedilol or Bisoprolol may be used as part of supportive therapy for mild / moderate heart failure.","Bradycardia, Hypotension, Bronchospasm, Fatigue (Can affect up to 10% of patients), Cold extremities, Sleep disturbances, Loss of hypoglycaemic awareness","Avoid higher doses and use with caution in patients with Asthmatic and COPD – risk of bronchospasm., Avoid in patients with history of frequent hypoglycaemia., Do not combine Beta-Blockers with rate-limiting Ca2+-Channel-Blockers (Verapamil / Diltiazem) in anti-hypertensive therapy, due to risk of heart-block.","Compliance is important – Patients may stop beta-blockers if they do not feel any better. Remind them that hypertension is asymptomatic but nonetheless a dangerous risk factor that needs controlled., Fatigue and cold extremities are common side-effects.","NA"
"Cardiovascular"," Non-Cardioselective Beta-Blockers ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29287","Propranolol, Carvedilol","Propanolol: Non-cardioselective beta-1-adrenoceptor antagonist., Carvedilol: Non-selective beta-1, beta-2 and alpha-1-adrenergic receptor antagonistic effects., Inhibits sympathetic stimulation in the heart and vascular smooth muscle.","Hypertension, Angina, Anxiety, Migraine prophylaxis, Post-MI prophylaxis, Carvedilol or Bisoprolol may be used as part of supportive therapy for mild / moderate heart failure.","Bradycardia, Hypotension, Bronchospasm, Fatigue (Can affect up to 10% of patients), Cold extremities, Sleep disturbances, Loss of hypoglycaemic awareness","Caution in diabetic patients – risk of deranged carbohydrate metabolism, Avoid in patients with Asthma and COPD – risk of bronchospasm, Do not combine Beta-Blockers with rate-limiting Ca2+-Channel-Blockers (Verapamil / Diltiazem) in anti-hypertensive therapy., Propanolol is lipid-soluble and is predominantly cleared by the liver. Avoid in liver impairment. Avoid abrupt withdrawal – risk of liver impairment.","Nightmares and sleep disturbances may occur., Compliance is important – Patients may stop beta-blockers if they do not feel any better. Remind them that hypertension is asymptomatic but nonetheless a dangerous risk factor that needs controlled., Fatigue and cold extremities are common side-effects.","NA"
"Cardiovascular"," ACE Inhibitors ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29288","Ramipril, Enalapril, Lisinopril, Perindopril","Inhibits conversion of Angiotensin I to Angiotensin II (a more potent systemic vasoconstrictor). , This action subsequently inhibits Aldosterone release from the adrenal cortex, depressing renal sodium and fluid retention, thereby decreasing blood volume. ","Hypertension, Heart Failure, Nephropathy, Prevention of Cardiovascular events in high risk patients","Dry cough (10% of Patients, causing cessation of treatment in 5%), Hypotension, Hyperkalaemia, Renal Impairment, Angioedema","Adverse drug reactions are higher in patients with:High-dose diuretic therapy / Hypovolaemia / Hyponatraemia / Hypotension / Unstable Heart Failure / Renovascular disease","Blood test required at 1-2 weeks to check electrolyte balance., Dry cough is a common side-effect.","NA"
"Cardiovascular"," Nitrates ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29289","Isosorbide Mononitrate, Glyceryl Trinitrate (GTN)","Converted to Nitric Oxide (NO), a potent vasodilator., Cardioselective, acting predominantly on coronary blood vessels, enhancing flow of blood to ischaemic areas of the myocardium., Additionally, reduces myocardial oxygen consumption by reducing cardiac preload and afterload.","Treatment of Angina, Severe hypertension (intravenous GTN is sometimes used in this setting)","Headache (incidence varies greatly, between 20-82%, causing cessation of treatment in 10%) , Postural Hypotension / Dizziness, Tachycardia ","Tolerance develops with long-term use., In order to avoid tolerance, patients should have a daily nitrate-free period., Isosorbide Mononitrate: Oral medication, longer duration of action than GTN., GTN: Rapidly inactivated by first pass (hepatic) metabolism and therefore cannot be digested – sublingual spray/tablet only. It can also be given intra-venously.","Headache is a common side effect initially, but incidence decreases the longer the patient is on the drug., Take GTN before activity that you know will bring on angina.","NA"
"Cardiovascular"," Rate-limiting Calcium Channel Blockers ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29290","Verapamil, Diltiazem","Prevent cellular entry of Ca2+ by blocking L-type calcium channels., Myocardial and Smooth muscle contractility depressed. Cardiac contractility will be reduced. , Dilate coronary blood vessels and reduce afterload., Antidysrhythmic actions due to prolonged atrioventricular node conduction – depresses heart rate.","Supraventricular arrhythmias, Treatment of angina, Hypertension","Constipation (up to 11.7% of patients), Flushing / Headache / Dizziness / Hypotension (up to 2.5% of patients), GI disturbances (up to 6% of patients), Bradycardia (up to 3.6% of patients), Peripheral oedema (up to 15% of patients), Dizziness / Headache / Hypotension (up to 4.3% of patients)","Contra-indicated in heart failure and left ventricular dysfunction due to potent negative inotropy., Avoid in bradycardia and hypotension., Do not use with beta-blockers.","Constipation is a common side effect with Verapamil., Ankle swelling is a common side effect with Diltiazem, hot weather making it worse., Compliance is important – Patients may stop Calcium-channel blockers if they do not feel any better. Remind them that hypertension is asymptomatic but nonetheless a dangerous risk factor that needs controlled.","NA"
"Cardiovascular"," Non Rate-limiting Calcium Channel Blockers ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29291","Amlodipine, Nifedipine, Felodipine","Prevent cellular entry of Ca2+ by blocking L-type calcium channels. , Myocardial and smooth muscle contractility depressed – these drugs mainly affect smooth muscle., Dilate coronary blood vessels and reduce afterload, These drugs do not lower heart rate (heart rate may increase)","Hypertension, Treatment of Angina","Ankle oedema (up to 15% of patients), Abdominal pain / Nausea, Palpitations (up to 4.5% of patients) , Flushing / Headache / Dizziness","Avoid in: Cardiogenic shock, Unstable Angina, Significant Aortic Stenosis.","Compliance is important – Patients may stop Calcium Channel Blockers if they do not feel any better. , Remind them that hypertension is asymptomatic but nonetheless a dangerous risk factor that needs controlled., Ankle swelling is a common side effect, hot weather making it worse. ","NA"
"Cardiovascular"," HMG CoA Reductase Inhibitors ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29292","Simvastatin, Atorvastatin, Pravastatin","Competitively inhibits HMG CoA Reductase; the rate-determining enzyme in the mevalonate pathway synthesis of cholesterol., This causes an increase in LDL-receptor expression, on the surface of hepatocytes., Increases hepatic uptake of cholesterol, reducing plasma cholesterol levels., Reduces development of athersclerotic plaques., Statins may have additional pleotropic effects.","Familial hypercholesterolaemia, Prevention of cardiovascular events in high-risk patients.","Myalgia (5-7% of patients), Myopathy (with creatine kinase elevation) and rhabdomyolysis are rare., GI disturbances (Varied symptoms; up to 6% of patients affected), Liver abnormalities – deranged LFT’s","Myalgia and Rhabdomyolysis are dose-related, begin with low dose, especially in patients with previous side-effects.","Report any unexplained muscle pains to their GP, who will check a creatine kinase blood level., Diarrhoea and abdominal pain may be present initially.","Hypothyroidism should be corrected before assessing need for statin use."
"Cardiovascular"," Cardiac Glycosides ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29293","Digoxin","Increases vagal parasympathetic activity and inhibits the Na+/K+ pump, causing a buildup of Na+ intracellularly., In an effort to remove Na+, more Ca2+ is brought into the cell by the action of Na+/Ca2+ exchangers., The buildup of Ca2+ is responsible for the increased force of contraction and reduced rate of conduction through the AV node. ","Heart Failure, Rate control in Atrial fibrillation","Nausea , Vomiting , Diarrhoea , Confusion","Digoxin has a narrow therapeutic index., Symptoms of digoxin toxicity are similar to effects of clinical deterioration., Additionally, the plasma-concentration is not a reliable indicator of toxicity., Digoxin-specific antibody fragments are used for life-threatening digoxin overdose., Digoxin has a long half-life and maintenance doses may only be required once-daily., Renal function, age and heart disease are major determinants for safe digoxin dosage.","Risk of toxicity.","Digitalis toxicity - **"
"Cardiovascular"," Anti-Arrhythmic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29294","Amiodarone","Amiodarone blocks cardiac K+ channels, prolonging repolarization of the cardiac action potential., Restores regular sinus rhythm., It also slows atrioventricular nodal conduction.","Supraventricular / ventricular arrhythmias.","Photosensitivity skin reactions (up to 75% of patients), Hypersensitivity reactions, Hyper / Hypothyroidism (linked to high iodine content), Pulmonary fibrosis, Corneal deposits (69-100% of patients), Neurological disturbances, GI disturbances / Hepatitis","Very long half-life, once daily dosing, can take weeks-months to achieve steady-state amiodarone-plasma concentrations., Thyroid function tests should be performed before treatment and every six months, or where symptomatic., LFTs should be taken during treatment.","Requires good compliance and attendance for monitoring blood tests., Avoid exposure to the sun, wear protective clothing and sunscreen., Report presence of rash after use – hypersensitivity risk.","NA"
"Anti-infectives"," Beta-lactams - Penicillins ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29295","Flucloxacillin, Amoxicillin, Benzylpenicillin, Penicillin V","Attaches to penicillin-binding-proteins on forming bacterial cell walls. , This inhibits the transpeptidase enzyme which cross-links the bacterial cell wall. , Failure to cross-link induces bacterial cell autolysis. , Amoxicillin provides some amount of gram-negative cover in addition to gram-positive drugs","Soft tissue infection , Staphylococcal endocarditis , Otitis externa, Non-severe community acquired pneumonia","Diarrhoea , Vomiting, Liver function impairment, Hypersensitivity reactions (severe reactions are rare; <0.05% are true hypersensitivity reactions)","NA","Return if symptoms persists after the course of antibiotics, may be infected with resistant organism., Diarrhoea is a common side effect., Report any incidence of a rash after use – risk of hypersensitivity reactions.","NA"
"Anti-infectives"," Beta-lactams - Cephalosporins ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29296","Ceftriaxone, Cephalexin","Attaches to penicillin-binding-proteins on forming bacterial cell walls., This inhibits the transpeptidase enzyme which cross-links the bacterial cell wall., Failure to cross-link induces bacterial cell autolysis., Less susceptible to beta-lactamases than penicillins., Provides both gram-positive and gram-negative cover.","Serious infection: septicaemia / pneumonia / meningitis","Hypersensitivity reactions (Low cross-reactivity in patients with true penicillin allergy – can be as low as 3-7%), Antibiotic-associated C.Difficile diarrhoea, Liver function impairment","Renal excretion., Longer half-life, needs to be given once daily.","Diarrhoea is a common side effect., Report any incidence of a rash after use – risk of hypersensitivity reactions.","NA"
"Anti-infectives"," Glycopeptides  ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29297","Vancomycin","Bactericidal, inhibiting cell-wall synthesis in Gram positive bacteria.","Severe gram positive infections, MRSA, Severe Clostridium difficile infection","Fever , Rash , Local phlebitis at site of injection, Nephrotoxicity (age-related risk; 6% of patients >65 years, 3% of patients <65 years on oral vancomycin) , Ototoxicity (Rare), Blood disorders, including neutropenia, Anaphylactoid reaction “red-man syndrome” if infusion rate too fast","Can either be given as a continuous intravenous infusion or as a pulsed infusion regimen, Long duration of action, can be given every 12 hours., Therapeutic drug-monitoring should be undertaken as Vancomycin has a narrow therapeutic range.","Risk of kidney damage., Patients should report any changes in hearing., Regular blood tests required for monitoring.","NA"
"Anti-infectives"," Aminoglycosides ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29298","Gentamicin","Binds to 30s ribosomal subunit, inhibiting protein synthesis, inducing a prolonged post-antibiotic bacteriostatic effect., Additionally, bactericidal action on bacterial cell wall results in rapid killing early in dosing interval and is prominent at high doses., Also provides a synergistic effect when used alongside other antibiotics (such as flucloxacillin or vancomycin in gram-positive infections).","Severe gram-negative infections (such as biliary tract infection, pyelonephritis, hospital-acquired pneumonia)., Some severe gram-positive infections (such as soft tissue infection and endocarditis).","Nephrotoxicity (2-10% of patients affected), Ototoxicity, These side-effects are related to prolonged exposure to high-drug concentrations.","Give high initial dose to take advantage of rapid killing, Leave long dosing interval to minimise toxicity, Measure trough level to ensure gentamicin is not accumulating and only prescribe further doses once this is confirmed., Try to limit use to approximately 3 days to minimise risk of side-effects.","Ask patients to report any change to their hearing., Risk of kidney damage so monitoring of drug levels and renal function tests are required.","NA"
"Anti-infectives"," Quinolones  ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29299","Ciprofloxacin","Interferes with bacterial DNA replication and repair., Broad-spectrum bactericidal antibiotics; provides both gram-positive and gram-negative cover.","Gram negative bacterial infection, Respiratory tract infection, Upper urinary tract infection, Peritoneal infection, Gonorrhoea, Prostatitis","GI toxicity, QT wave prolongation, Clostridium difficile infection (antibiotic associated diarrhoea), Tendonitis (this is extremely rare, but is an example of a type B adverse drug reaction)","NA","Risk of diarrhoea after use.","NA"
"Anti-infectives"," Macrolides ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29300","Clarithromycin, Erythromycin","Binds to 50s ribosomal subunit, Inhibits bacterial protein synthesis.  ","Atypical organisms causing pneumonia / Severe community acquired pneumonia, Severe campylobacter infection, Mild / moderate skin and soft-tissue infection, Otitis media, Lyme disease, Helicobacter pylori eradication therapy","Diarrhoea , Vomiting, QT wave prolongation, Ototoxicity with long-term use","Uses hepatic enzyme Cytochrome P450 pathway, Can interact with all drugs using this pathway, especially Simvastatin, Atorvastatin and Warfarin. ","Risk of Diarrhoea, Senses of smell and taste may be disturbed during therapy., Tooth and tongue discoloration may occur during therapy.","NA"
"Anti-infectives"," Inhibitors of Folate Synthesis ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29301","Trimethoprim","Inhibits folate metabolism pathway and leads to impaired nucleotide synthesis, Therefore interferes with bacterial DNA replication.","First line antibiotic in uncomplicated UTI., Acute / chronic bronchitis, Pneumocystis pneumonia (PCP), Good range of action against gram negative and gram positive bacteria. Including some MRSA cover.","Elevated serum creatinine, Hyperkalaemia, Depressed haematopoiesis, Rash and GI disturbance both relatively common","Penetrates well into the prostate, suitable for men with uncomplicated UTI, Avoid in the first trimester of pregnancy, Resistant organisms are a major problem in clinical use., Hyperkalaemia is more common in patients with impaired renal function.","Blood tests required in those at risk of hyperkalaemia., Return to the doctor if symptoms do not clear after trimethoprim course, resistance does occur., Rash and GI disturbances are common adverse reactions.","NA"
"Anti-infectives"," Anti-Virals ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29302","Aciclovir","A guanosine derivative, converted to triphosphate by infected host cells., Aciclovir triphosphate then inhibits DNA polymerase, terminating the nucleotide chain and inhibiting viral DNA replication. ","Herpes simplex infection, Varicella zoster infection","Nausea , Vomiting, Local inflammation at infusion site (IV only)","Can be given orally, intravenously or topically., Penetrates well into the CSF with CSF concentrations being 50% concentration of that of plasma. , Excreted by the kidneys so dose adjustment is needed in renal impairment.","Multiple/repeat doses may be required in immunosuppressed patients.","Type of infection/recurrent infection may prompt HIV testing."
"Respiratory"," Beta-Adrenergic Bronchodilators ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29303","Salbutamol ","Short-acting Beta-2 adrenoceptor agonists (SABA), Relaxes bronchial smooth muscle, inducing bronchodilation., Inhibit pro-inflammatory cytokine release from mast cells and TNF-α release from monocytes, reducing airway inflammation. , Increase mucus clearance from the airways by stimulating cilia action.","Asthma, COPD","Tremor , Tachycardia / cardiac dysrhythmia, Headache , Sleep disturbances","Only a small percentage of inhaled drug reaches target in the airways – a spacer may improve drug delivery","Check inhaler technique, review the need for spacer / nebuliser., In exercise-induced-asthma, a dose immediately before exercise can reduce incidence of symptoms., If required more than once daily, treatment needs reviewed.","NA"
"Respiratory"," Beta-Adrenergic Bronchodilators ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29304","Salmeterol","Long-acting Beta-2 adrenoceptor agonist (LABA), Relaxes bronchial smooth muscle, inducing bronchodilation., Inhibit pro-inflammatory cytokine release from mast cells and TNF-α release from monocytes, reducing airway inflammation. , Increase mucus clearance from the airways by stimulating cilia action.","Asthma, COPD","Tremor , Tachycardia / cardiac dysrhythmia, Headache , Sleep disturbances","Not to be commenced in patients with rapidly deteriorating asthma – slower onset of action than SABA’s.","Report any deterioration in symptoms following initiation of LABA., Do not exceed stated dose., Seek medical advice when stated dose fails to control symptoms.","NA"
"Respiratory"," Anti-Muscarinic Bronchodilators ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29305","Tiotropium, Ipratropium Bromide","Muscarinic receptor (M3) antagonists producing bronchodilatory effects. , Reduces mucus secretion and may increase bronchial mucus clearance by stimulating cilia.","Asthma, COPD, Rhinitis","Dry mouth , Cough, Constipation","Inhaled and poorly absorbed into the circulation – unable to affect systemic muscarinic/cholinergic receptors, Nebulised Ipratropium Bromide should always be administered via a mouth piece to minimize the risk of acute angle closure glaucoma.","Good inhaler technique improves efficacy., Cough may arise.","NA"
"Respiratory"," Inhaled Corticosteroids ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29306","Beclomethasone","Anti-inflammatory effect on the airways., Decrease formation of pro-inflammatory cytokines., Up-regulates beta-2-adrenoreceptors in airways.","Treatrment of COPD, Treatment of asthma","Oral Candidiasis (thrush), Adrenal suppression, Osteoporosis","Takes several weeks to months for full effects of therapy., Spacer devices can  reduce risk of thrush and improve drug delivery.","If on higher dose, carry a steroid card., Increase dose during periods of illness.","NA"
"Respiratory"," Anti-Histamines (H1 receptor antagonists) ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29307","Chlorpheniramine, Desloratidine, Fexofenadine, Hydroxyzine","Antihistamine; H1 receptor antagonist., Inhibits histamine-mediated contraction and vasodilation of the bronchial smooth muscle.","Anaphylaxis, Hay fever, Urticaria, Sedation","Drowsiness, Tinnitus","Renally excreted, Sedation arises from central nervous system H1 antagonism (second generation H1 antagonists do not cross the blood brain barrier in therapeutic doses).","Do not operate heavy machinery., Do not drive.","NA"
"Neurology/Psychiatry"," Dopamine Precursor ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29308","Levodopa","NA","Parkinson’s Disease ","Dyskinesia, Compulsive disorders, Hallucinations, Nausea, GI upset","Converted to dopamine in peripheries (which can cause the motor side effects), Given with a dopamine decarboxylase inhibitor or COMT inhibitor to reduce these effects, Short half life – 50 to 90 mins, Rapidly absorbed from the proximal small intestine via the large neutral amino acid (LNAA) transport carrier system","Dyskinesia common, Reduced efficacy over time, Avoid abrupt withdrawal","NA"
"Neurology/Psychiatry"," Dopamine Agonists ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29309","Apomorphine , Pramipexole , Bromocriptine , Pergolide , Rotigotine","Stimulate post synaptic dopamine receptors, Apomorphine: non selective D1 and D2 dopamine subfamily of receptors, Pramipexole:  selective D3 receptor","Parkinson’s Disease","Apomorphine: pain at site of injection, nausea, vomiting, Pramipexole: hallucinations, nausea, drowsiness, involuntary movements","Apomorphine: highly emetic, hence limited use. Short half life (40 mins). Needs to be given via injection., Pramipexole: Cimetidine increases its toxicity, long half life (8 hrs), Dopamine Agonists have reduced efficacy over time","Apomorphine can only be injected, Dopamine agonists are weaker then L-DOPA so treatment may be modified in time.","NA"
"Neurology/Psychiatry"," Catechol-o-methyl transferase Inhibitor ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29310","Entacapone","Therefore more levodopa reaches the brain","Parkinson’s Disease in conjunction with L-DOPA and dopamine decarboxylase inhibitor","Dyskinesia (common, up to 27%), Nausea (11%), Abdominal pain, Vomiting, Dry mouth, Dizziness ","Rapidly absorbed","Urine may turn brown – normal, Could become lightheaded/dizzy while doing daily activities, Avoid abrupt withdrawal","NA"
"Neurology/Psychiatry"," Anti-Epileptic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29311","Carbamazepine","Voltage gated Na+ channel blocker on pre-synaptic membrane, Blocks the Na+ influx; reduces neuronal excitability and decreases the action potential","Epilepsy, Trigeminal Neuralgia, Neuropathic pain","Dizziness, Dry mouth, Ataxia, Fatigue, Headache, Diplopia, Blurred vision, Hyponatraemia, Stevens-Johnson’s syndrome (rarely <0.01%)","Response to the drug can be variable, Enzyme inducer of cytochrome P450; induces metabolism of itself, Interactions with other anti-convulsants, The transporter that can confer drug resistance is RALBP1, Grapefruit can significantly increase serum levels of this drug, HLA-B*1502 allele raises the risk for SJS; avoid in these patients","Avoid alcohol, Avoid grapefruit juice","NA"
"Neurology/Psychiatry"," Anti-Epileptic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29312","Sodium Valproate","Weak sodium ion channel blocker, Inhibitor of GABA degrading enzymes, Increased GABA stops action potential","Epilepsy, Bipolar disorder, Depression","Nausea, Diarrhoea, Gastric irritation, Weight gain, Hyponatraemia, Behavioral disturbances (less common <10%), Confusion (less common <10%), Stevens-Johnson Syndrome (rare <0.1%)","Enzyme inhibitor of cytochrome P450, Rapid absorption from GI tract – varies with formulation administered (liquid, solid, powder) and when administered (post-prandial or fasting), Can cause interactions with other anti-epileptic drugs.","Avoid alcohol, Take with food, Do not take with milk, Liver function test must be monitored before and during the initial 6 months","NA"
"Neurology/Psychiatry"," Anti-Epileptic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29313","Phenytoin","Acts as a voltage-gated Na+ channel blocker on the pre-synaptic neuronal membrane, Limits action potential transmission, Hence limiting spread of seizure activity","Epilepsy (including status epilepticus), Trigeminal neuralgia","Insomnia, Headache, Rash, Constipation, Vomiting, Gingival hyperplasia, Liver damage, Stevens-Johnson Syndrome (rare), Leucopenia (rare), Thrombocytopenia (rare)","Enzyme inducer of cytochrome P450, Can cause interactions with other anti-epileptic drugs, Narrow therapeutic index, Relationship between dose and plasma concentration is non-linear","Avoid alcohol, Do not take calcium, aluminum, magnesium or iron supplements within 2 hours of ingestion, Take with food to reduce irritation","NA"
"Neurology/Psychiatry"," Anti-Epileptic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29314","Lamotrigrine","Varied mechanism of action, Inhibits voltage-gated Na+ channels and/or Ca2+ channels, Acts on pre-synaptic neuronal membrane, Reduces action potential and excitatory signals","Epilepsy (used for both partial and generalized seizures), Depressive episodes associated with Bipolar disorder","Nausea, Vomiting, Diarrhoea, Tremor, Insomnia, Blurred vision, Aggression, Skin reactions including Sevens-Johnson syndrome and toxic epidermal necrolysis (rarely)","Half-life doubles in chronic renal impairment so dose adjustment is required.","Take without regard to meals, Seek medical advice if any rash or signs/symptoms of hypersensitivity.","NA"
"Neurology/Psychiatry"," Anti-Epileptic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29315","Levetiracetam","SV2A is a synaptic vesicle protein required for neurotransmitter release, Levetiracetam blocks this and reduced neurotransmitter release, Induces an anti-epileptic effect","Epilepsy","Headache, Fatigue, Anxiety, Irritability, Drowsiness, Constipation","Rapidly and almost completely absorbed after oral administration (99%), Food does not affect bioavailability, Cytochrome P450 is not involved in its metabolism","It might affect your ability to drive or operate machinery, Not recommended during pregnancy and breastfeeding","NA"
"Neurology/Psychiatry"," Selective Serotonin Reuptake Iinhibitors (SSRIs) ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29316","Citalopram , Fluoxetine , Paroxetine , Escitalopram , Sertraline","Inhibition of reuptake of serotonin at the serotonin reuptake pump of the synaptic cleft (in the central nervous system), Increases serotonin stimulation of somatodendritic 5-HT1A and terminal autoreceptors ","Depression, Bulimia, Obsessive Compulsive Disorder","NA","SSRIs bind with less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs. This leads to fewer side effects., Less dangerous in overdose than tricyclic antidepressant drugs.","Be wary with alcohol - toxicity possible, Improveemnt in depressive symptoms may take several weeks to occur., Abrupt discontinuation from SSRIs may cause withdrawal symptoms (fatigue, tremor, sweating)","NA"
"Neurology/Psychiatry"," Tricyclic Antidepressants ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29317","Amitriptyline, Imipramine, Doxepin","Stops the reuptake of monoamines, Binds to monoamine pump at pre-synaptic cleft, The reduced reuptake of norepinephrine and/or serotonin combats depression","Depression, Panic disorders, Neuropathic pain","Sedation (anti-histaminergic effects), Postural hypotension, tachycardia (anti-adrenergic effects), Urinary retention, dry mouth, blurred vision / diplopia (anti-cholinergic effects)","Blocks histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects, Well absorbed orally, First pass effect (liver)","Reduction in depressive symptoms may take several weeks to appear.","Tricylcic antidepressant overdose can be serious causing seziures and cardiac arrythymias."
"Neurology/Psychiatry"," Anti-Psychotic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29318","Act non selectively on D1-like and D2-like receptors, Varying effects on dopamine and serotonin receptors","NA","Schizophrenia, Mania, Delusions, hallucinations, Behavioral problems, Anti-emetic (Haloperidol)","Sedation (anti-histaminergic effect), Postural hypotension, tachycardia (anti-adrenergic effect), Urinary retention, dry mouth, blurry vision (anti-cholinergic effect)","Have effects on numerous receptor systems within the central nervous system.","Symptoms may not always disappear while on medication, Dosage may have to be increased if no improvement after a few weeks","NA"
"Neurology/Psychiatry"," Benzodiazepines ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29319","Diazepam, Lorazepam, Midazolam","Increases GABA affinity for GABA receptor, GABA binding to receptor increases chloride flow through chloride channels, Hyperpolarization occurs - reducing activity of limbic, thalamic and hypothalamic areas of the brain.","Anxiety, Epilepsy, Muscle spasm, Alcohol withdrawal","Sedation, Ataxia, Altered mental status, Insomnia","Diazepam is a long acting benzodiazepine with active metabolites so can accumulate in longer term use and in patients with liver failure. It can be given orally, rectally or parenterally., Lorazapam accumulates less with long term use or in patients with liver failure so is preferred in this setting. It cannot be given rectally., Midazolam is a potent and short acting benzodiazepine typically given parenterally, although buccal preparations exist.","Monitor breathing and report if severe breathlessness or palpitations, Only prescribed for short terms – risk of addiction","NA"
"Immuno-modulators"," Corticosteroids (Glucocorticoids) ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29320","Prednisolone, Hydrocortisone, Dexamethasone, Hydrocortisone, Betamethasone, Clobetasone, Methyprednisolone, Hydrocortisone, Triamcinolone","NA","Replacement therapy in adrenal insufficiency, Post-transplantion immunosupression, Treatment of exacerbations of a variety of inflammatory conditions (including eczema, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis)., Treatment of acute asthma","Sleep disturbance, Mood disturbance / psychosis, Hyperglycemia, Immunodeficiency, Easy bruising, Moon-faced, Increased abdominal fat, Glaucoma, Striae, Hypertension, Gastric irritation","A variety of different preparations are available described above., Drugs have differing degress of glucocorticoid and mineralocorticoid activity (discussed below).","Avoid alcohol and caffeine, Take with food to avoid gastric irritation, Don’t stop abruptly, Always tell doctors they are on prenisolone, Carry steroid card, Take higher dose when ill","Corticosteroids refer to both glucocorticoids or mineralocorticoids, Glucocorticoids are different from mineralocorticoids by their receptors, target cells and function, Different corticosteroids have differing glucocorticoid or mineralocorticoid activity, Prednisolone: Predominant glucocorticoid activity. Low mineralocorticoid activity, Betamethasone: Potent glucocorticoid activity. No mineralocorticoid activity, Hydrocortisone: Good glucocorticoid and mineralocorticoid activity, Dexamethasone: Potent glucocorticoid activity. Minimal or no mineralocorticoid activity, Fludrocortisone: Mild to moderate glucocorticoid activity. Potent mineralocorticoid activity, Increased resorption of water, Increased resorption of sodium, Increased renal excretion of potassium"
"Immuno-modulators"," Anti-TNF agents ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29321","Etanercept – receptor fusion protein, Infliximab – monoclonal antibody, Adalimumab – monoclonal antibody","Anti-TNF-α and anti-TNF-β, Blocks its interactions with TNF cell receptors, TNF α and β produced from macrophages and T cells, Stimulates cytokine – IL1, IL8, IL6, Reduces inflammation","Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Juvenile arthritis","Injection site reactions, Flu-like symptoms (fever, headache, runny nose), Immune deficiency – in particular risk of legionella and listeria infection and reactivation of tuberculosis","Given parenterally (subcutaneous injection).","Maintain good hygiene and report symptoms of infection early.","NA"
"Immuno-modulators"," Immunosuppressant Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29322","Methotrexate, Azathioprine , Mercaptopurine","Disrupt DNA synthesis, Azathioprine: blocks purine synthesis mainly in lymphocytes, Methotrexate: stops the action of the enzyme dihydrofolate needed for production of DNA","Post transplantation immunosuppression, Inflammatory bowel disease, Renal vasculitis, Paediatric leukaemia (methotrexate is used)","Bone marrow suppression (leucopenia), Risk of infection, Nephrotoxicity, Hepatotoxicity, Seizures, GI upset, Mucosal ulceration, Alopecia","Do not cross the blood brain barrier, Undergo hepatic metabolism, Oral absorption is dose dependent, Patients with low levels of thiopurine methyltransferase activity are more prone to azathioprine and mercaptopurine related marrow suppression","Limit caffeine intake, Take without regard to meals","NA"
"Gastrointestinal"," Proton Pump Inhibitors ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29323","Omeprazole, Lansoprazole, Pantoprazole","Bind to H+/K+ ATPase pump on gastric parietal cells, Reduces HCl production and hence reduced gastric acidity","Peptic ulcers, Gastro-oesophageal reflux disease, H.Pylori infection, Prophylaxis in patients receiving long term NSAIDs, Zollinger-Ellison syndrome, Zollinger-Ellison syndrome","Nausea, Vomiting, Insomnia, Vertigo, Headaches","Omeprazole is an inhibitor of cytochrome P450 enzymes","Avoid alcohol, Take 30-60mins before food","NA"
"Gastrointestinal"," H2 Receptor Antagonists ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29324","Ranitidine, Cimetidine, Famotidine, Nizatidine","Histamine binds to H2 receptors on gastric parietal cells stimulating gastric acid secretion, Drugs antagonise the effect of histamine at these H2 receptors, Reduced cAMP and hence reduced activity of H+/K+ ATPase pump","Peptic ulcer, Gastro-oesophageal reflux disease, Zollinger-Ellison syndrome","Headache, Dizziness, Diarrhoea, Reduced B12 absorption, Gynaecomastia","Cimetidine is an inhibitor of cytochrome P450 enzymes.","Avoid high protein diet, Take without regard to meals","NA"
"Gastrointestinal"," Laxatives ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29325","Lactulose, Senna","Lactulose – reduces water reabsorption in intestine; it pulls water into the bowel and thus promotes distention and movement, Senna – stimulant / irritant agent","Constipation, Pregnancy, Prophylaxis in opiate analgesic use","Dehydration, Salt loss, Abdominal cramps, Fatigue","Lactulose - consists of monosaccharides: fructose and galactose. Breakdown of this in the intestine by colonic bacteria increases osmotic pressure , Senna - recommended for short term use only. Risk of organ failure with long term use or abuse.","Take liberally without regard to meals","NA"
"Gastrointestinal"," Anti-Emetic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29326","Cyclizine","Histamine H1 receptor antagonist, Acts on vomiting center in the medullary region, Mild anti-cholinergic and anbti-muscarinic effects","Nausea and vomiting, Motion sickness, Vertigo and dizziness, Prophylaxis alongside chemotherapy and opiate analgesic use","Headache, Sedation, Diarrhoea"," It can also be a central nervous system depressant","Avoid alcohol, Food may reduce irritation, Take without regard to meals","NA"
"Gastrointestinal"," Anti-Emetic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29327","Metoclopramide","Dopamine (D2) receptor antagonist, Raises activity in the chemoreceptor trigger zone – reducing input from afferent visceral nerves, Also increases gastric emptying and intestinal transit, Reduced oesophageal reflux","Nausea, Vomiting, To increase gastric emptying","Dystonia (due to dopamine antagonism), Confusion, Dizziness, Diarrhoea, Parkinsonism with long term use","Can be given orally or parenterally, Dystonic reactions and movement disorders are more common at the extremes of age so caution is needed in these groups","Avoid alcohol, Take 30 mins before meal","NA"
"Gastrointestinal"," Anti-Emetic Drugs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29328","Prochlorperazine","Penothiazine anti-psychotic drug used as an anti-emetic, Dopamine (D2) receptor antagonist, Causes increased dopamine turnover (in mesolimbic and chemoreceptor trigger zone)","Nausea and vomiting, Used as an adjunct in some psychotic disorders","Dry mouth, Tachycardia, Restlessness, Drowsiness","Anticholinergic and alpha-adrenergic receptors antagonism occurs leading to; sedation, muscle relaxation, and hypotension., The dose differs substantially when given parenterally","Avoid alcohol and caffeine, Take with food along with a full glass of water","NA"
"Renal"," Thiazide Diuretics ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29329","Bendroflumethazide, Indapamide, Chlortalidone","Inhibit Na+/Cl- transporter at the distal convoluted tubule and collecting duct, Increases Na+, Cl- and water excretion ","Hypertension, Oedema of cardiac / renal / hepatic / iatrogenic origin","Hypokalaemia, Hypomagnesaemia, Hyponatraemia, Hypercalcaemia, Hyperuricaemia, Reduced glucose tolerance, Hypersensitivity reactions – rashes, pneumonitis  (less common)","Produces diuresis quickly within 1-2 hours, NSAIDs reduces efficacy of thiazide diuretics","Urinary frequency usually not affected, Report if sudden rash, Make aware of risk of electrolyte imbalance","NA"
"Renal"," Loop Diuretics ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29330","Furosemide, Bumetanide, Torasemide","NA","Hypertension, Hyperkalaemia, Heart failure, Cirrhosis of liver (fluid retention), Nephrotic syndrome","Hypokalaemia, hypovolaemia, hyperuricaemia (increased urate reabsorption), Metabolic acidosis, Abdominal pain, Ototoxicity","60% absorbed in patients with normal renal function, Renal and hepatic excretion – increased half life for patients with renal or hepatic disease","Avoid excess alcohol, Urinary frequency increases","NA"
"Renal"," Insulin ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29331","Novorapid, Glargine, Humalog Mix","Insulin increases cellular uptake of glucose, It stimulates glycogenesis, encourages DNA synthesis and promotes release of growth hormone, Several types of exogenous insulin: Short acting: NovorapidLong acting: GlargineFast-acting and Intermediate-acting mix: Humalog Mix, Short acting: Novorapid, Long acting: Glargine, Fast-acting and Intermediate-acting mix: Humalog Mix","Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hyperkalaemia (in conjunction with dextrose)","Hypoglycaemia, Sweats / shakes / tachycardia / headache / weakness / fatigue (typically symptoms of hypoglycaemia), Oedema, Injection site reactions","Patients are given varying types of insulin combinations based on their activities and preferences, Given subcutaneously and short acting insulin (actrapid) can be given intravenously.","Only in the form of injection, Compliance important, Never skip meals while on insulin","NA"
"Endocrine"," Sulphonylureas ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29332","Gliclazide, Glimepiride","Stimulates B cells of the pancreas to produce more insulin, Increase cellular glucose uptake and glycogenesis; reduces gluconeogenesis, Glicazide is short acting (12 hours approx)","Type 2 diabetes mellitus along with diet and exercise","Hypoglycaemia, Rashes, Nausea, Vomiting, Stomach pain, Indigestion, Weight gain","Renally excreted so accumulate in renal failure, Glimepiride is long acting sulphonylureas","Compliance important, Maintain consistent diet, Avoid alcohol","NA"
"Endocrine"," Biguanides ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29333","Metformin","Increase the activity of AMP-dependent protein kinase (AMPK), This inhibits gluconeogenesis, Reduces insulin resistance","Type 2 diabetes mellitus along with diet and exercise, Metabolic and reproductive abnormalities associated with Polycystic ovarian syndrome","Diarrhoea, Nausea, Vomiting, Taste disturbances, Lack of apetite, Risk of lactic acidosis in patients with renal failure","Not recommended in pregnancy and renal failure (eGFR <30 mls/min), Absorption reduces when taken with food","Take them at the same time everyday, Avoid alcohol","Does not increase weight"
"Endocrine"," GLP-1 (glucagon like peptide) Agonist ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29334","Exanatide, Liraglutide","GLP-1 is a hormone that is released after meals to increase insulin secretion, These drugs is a GLP-1 agonist, It increases insulin secretion, decreases glucagon secretion and reduces hunger","Type 2 Diabetes Mellitus (in association with excess weight).","Hypoglycaemia, Nausea, Vomiting, Diarrhoea","It can lower glucose alone, but when given in combination with metformin, sulfonylureas, and/or insulin it can improve glucose control, Renally excreted so dose adjustment needed in renal failure","Only given as injections, Twice a day","NA"
"Endocrine"," Synthetic Thyroid Hormone ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29335","Levothyroxine","Thyroxine increases the metabolic rate of all tissues in the body, Synthetically prepared levo-isomer of thyroxine, Acts like T4 and gets converted to T3 in the liver and kidney, Maintain brain function, food metabolism, and body temperature, among other effects","Hypothyroidism, Chronic lymphocytic thyroiditis","Chest pain, Coma, Diarrhoea, Tachycardia, Itching, Muscle cramps","Primarily eliminated by the kidneys, Intravenous formulations are available, The half-life is long (6 to 7 days) so thyroid function should be rechecked 6 weeks after a dose adjustment","Take 30-60 minutes before breakfast.","NA"
"Endocrine"," Anti-Thyroid Drugs - Thionamides ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29336","Carbimazole, Propylthiouracil","Reduces activity of peroxidase enzyme (required for the production of thyroid hormones), May also reduce peripheral conversion of T4 to T3, Carbimazole is a pro-drug","Hyperthyroidism, Thyrotoxicosis, Preparing patients for thyroid surgery","Rash, Agranulocytosis, Sore throat","Carbimazole is rapidly metabolised to thiamazole. The mean peak plasma concentration occurs one hour, It crosses the placenta and can be found in breast milk, The effect of anti-thyroid drugs can take several weeks to occur so are usually prescribed alongside a beta-blocker to reduce symptoms of hyperthyroidism","Compliance is important, Regular blood checks will be needed to monitor treatment response and renal, hepatic function and full blood counts.","NA"
"Endocrine"," Bisphosphates ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29337","Alendronate (Alendronic Acid), Ibandronate","Inhibits osteoclast bone resorption, No effect on bone formation","Post menopausal osteoporosis, Reduces risk of vertebral and hip fractures, Paget's disease of bone","Abdominal pain, Dyspepsia, Acid regurgitation, Dysphagia, Headache","Bioavailability reduces with breakfast (with coffee or orange juice)","Administer 30 mins before food, Avoid caffeine ","NA"
"Endocrine"," Oral Contraceptive Pill ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29338","Microgynon (combined oral contraceptive pill), Cerazette (progestogen only pill)","A progestin (synthetic form of progesterone) along with an oestrogen (combined oral contraceptive pill) or a progestin alone (progestegen only pill), Acts on female reproductive tract, the mammary glands, hypothalamus and the pituitary gland, Reduces the production for gonadotropin releasing hormone (GnRH), Blunts the LH surge that stimulates ovulation","Contraception, Menopausal and postmenopausal disorders, Polycystic ovarian syndrome","Mood swings, Headache, Breast tenderness, Increased risk of breast and ovarian cancer (small), Increased risk of venous thromboembolic disease (small)","Antibiotics and some enzyme inducers (St John's Wort) can reduce efficacy.","Take at the same time everyday - compliance is critical for efficacy, Take with food, Use alternative forms of contraception when taking concurrent antibiotics or enzyme inducers","NA"
"Musculoskeletal and Pain"," Opiates / Opioids  ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29339","Codeine ","Opioid receptor agonist; acts on mu, kappa and delta on presynaptic neurones. This gives numerous effects that increase nociceptive thresholds throughout the central and peripheral nervous system.","Mild to moderate pain, Persistent dry cough, Diarrhoea","Nausea, Vomiting, Constipation, Biliary spasm, Headache on withdrawal","Metabolised to morphine which is responsible for analgesic effects., Predominantly metabolised by the liver., Active metabolites are excreted in the urine so can accumulate in renal failure., 10% of population resistant to codeine’s analgesic properties as they lack the demethylating enzyme that converts it to morphine.","Can be taken with paracetamol for a better analgesic effect., Constipation is a likely side effect.","NA"
"Musculoskeletal and Pain"," Opiates / Opioids  ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29340","Morphine","Opioid receptor agonist; acts on mu, kappa and delta on presynaptic neurones. This gives numerous effects that increase nociceptive thresholds throughout the central and peripheral nervous system.","Acute severe pain (including in setting of myocardial infarction), Acute pulmonary oedema, Chronic pain","Nausea, Vomiting, Abdominal pain, Constipation, Respiratory depression, Sedation","Predominantly metabolised by the liver., Opioid receptor agonist; acts on mu, kappa and delta on presynaptic neurones. This gives numerous effects that increase nociceptive thresholds throughout the central and peripheral nervous system., Metabolites are active and can accumulate in renal failure., Accumulation can result in respiratory and central nervous system depression.","Often given with an anti-emetic to reduce nausea / vomiting.","NA"
"Musculoskeletal and Pain"," Opiates / Opioids  ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29341","Oxycodone","Opioid receptor agonist; acts on mu, kappa and delta on presynaptic neurones. This gives numerous effects that increase nociceptive thresholds throughout the central and peripheral nervous system.","Moderate to severe pain relief in cancer patients, Postoperative pain, Severe pain","Nausea, Vomiting, Abdominal pain, Constipation","Available as long and short acting preparations, Predominantly metabolised by the liver., Often administered via slow intravenous/subcutaneous  infusion.","Nausea and constipation are common side-effects.","NA"
"Musculoskeletal and Pain"," Non-Selective NSAIDs ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29342","Ibuprofen, Diclofenac","Non-selective inhibition of cyclo-oxygenase (COX 1 and 2) enzymes, decreasing key inflammatory mediator prostaglandin from being synthesised., Thereby reduces pain, inflammation and swelling.","Mild to moderate pain relief, Rheumatic disorders (such as rheumatoid arthritis and osteoarthritis), Fever (anti-pyretic effect)","Gastric and duodenal ulceration (risk increases with duration of therapy and dosage), Nausea, Diarrhoea, Avoid in pregnancy particularly 3rd trimester (risk of closure of fetal ductusarteriosus in utero and pulmonary hypertension in newborn), Renal impairment, Hyperkalaemia","Pain relief starts soon after the first dose, full analgesic effects can take up to one week and anti-inflammatory effects can take up to three weeks., Avoid in patients with renal impairment – use lowest dose, for shortest time if unavoidable., Caution should be used in the elderly – risk of gastrointenstinal bleeds.","Risk of stomach bleeds if on long-term use., Take with food or milk, to reduce abdominal discomfort and to reduce the risk of bleeding., Take only when required. , In elderly patients a proton pump inhibitor is usually given alongside NSAID drugs","NA"
"Musculoskeletal and Pain"," Selective NSAIDS ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29343","Celecoxib","Selective inhibitor of COX-2, decreasing key inflammatory mediator prostaglandin from being synthesised., Thereby reduces pain, inflammation and swelling.","Pain and inflammation in: osteoarthritis / rheumatoid arthritis / ankylosing spondylitis","Gastric and duodenal ulceration (Risk increases with duration of therapy and dosage), Nausea, Diarrhoea, Renal impairment, Hyperkalaemia","Less incidence of serious gastrointestnal bleeds (GI) / ulceration compared to non-selective NSAIDs., Presumed higher risk of cardiovascular events, compared to non-selective NSAIDs., Avoid in patients with renal impairment – use lowest dose, for shortest time if unavoidable., Caution should be used in the elderly – risk of GI bleeds., Avoid in pregnancy particularly 3rd trimester (risk of closure of fetal ductusarteriosus in utero and pulmonary hypertension in newborn).","Risk of stomach bleeds if on long-term use., Take with food or milk, to reduce abdominal discomfort and to reduce the risk of bleeding., Take only when required.","NA"
"Musculoskeletal and Pain"," Paracetamol ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29344","Paracetamol","A weak cyclooxygenase enzyme (COX) inhibitor with selectivity for brain COX., It therefore lacks peripheral anti-inflammatory actions but is useful in increasing the threshold for nociceptive activation by inhibiting prostaglandin synthesis and its effects centrally.","Mild to moderate pain relief, Fever (anti-pyretic effect)","Rash / blood disorders (rare)","Overdose must be avoided – severe liver damage can occur and can be fatal., Careful dosing in younger patients and patients with low body weight (reduce dose to 500mg 4-6 hourly, qid in patients <50kg)","Take only the prescribed amount and be wary of other over-the-counter medications that may contain paracetamol. ","NA"
"Musculoskeletal and Pain"," Xanthine Oxidase Inhibitors ","https://moodle.gla.ac.uk/mod/data/view.php?d=424&rid=29345","Allopurinol","Reduces synthesis of uric acid by competitively inhibiting xanthine oxidase., Reduces serum uric acid level","Prophylaxis of gout, Prophylaxis of calcium oxalate renal stones, Hyperuricaemia associated with cancer chemotherapy","Rash, Hypersensitivity, Gastrointestinal disturbances, Neutropenia (rare)","Not used to treat acute attack of gout, can exacerbate the inflammation, so should not be started during acute episodes., Cytochrome P450 enzyme inhibitor, Azathioprine metabolism affected.","Rash and abdominal disturbances are relatively common., Rash should be reported to a doctor, Keep taking allopurinol, even when there is no sign of gout., In order to prevent an exacerbation of gout a NSAID or cochicine is often prescribed for the first 3 months of therapy","NA"
